Vital Laboratories Private Limited
Surendrakumar Yadav is an accomplished professional in manufacturing operations with extensive experience in the pharmaceutical and life sciences sectors. Currently serving as GM of Manufacturing Operations at Vital Laboratories Private Limited since February 2023, Surendrakumar oversees the entire operations of the manufacturing plant, focusing on production targets, technology transfer, and compliance with cGMP standards for regulatory audits. Previous roles include AGM of Manufacturing Production at Ipca Laboratories Limited, where responsibilities included production planning, team training on cGMP compliance, and ensuring safety protocols. Surendrakumar co-founded Jaivahini Private Limited, a life sciences startup, and has held several managerial positions across notable organizations, emphasizing technology transfer, process optimization, and regulatory compliance. Educational qualifications include a B.Sc. in Technology of Pharmaceuticals & Fine Chemicals from UDCT-Mumbai and a Bachelor of Science in Chemistry from the University of Mumbai.
Vital Laboratories Private Limited
We, Vital Laboratories Private Limited, are manufactures of pharmaceutical API’s. We started our journey in 1998 with manufacturing Quinine Derivatives and today we are one of the largest manufacturers of Quinine Derivatives globally. We have enlarged our product basket to more than 45 API’S in our product portfolio covering various therapeutic segments. We manufacture various herbal based APIs and synthetic APIs; and market to both Domestic and International Markets. We have a strong portfolio of products having Herbal origin which involves the process of Extraction of the product from medicinal plants. Besides API of herbal origin, we have built up a strong portfolio of Synthetic APIs. Our product portfolio of APIs covering various therapeutic segments like anti-malarial, anti-spasmodic, vitamins, auto-immune, anti-viral, anti- bacterial, muscle relaxants, NSAIDs, etc. Vital is a partner to almost all major pharmaceutical companies in India and has a global reach through its strategic partnerships. Our Company’s strength and its growth is a result of our philosophy to manufacture API right from scratch. Hence ensuring backward integration for most of our products is a key to our success. In the pursuit of our endeavour towards backward integration, through the cultivation in our farms in Australia, we have secured our business of Hyoscine derivatives. Similar integrations in Quinine derivatives and other businesses have strengthened Vital’s position as a reliable partner.